Manufacturing / Pharmaceutical Preparations
Sarepta Therapeutics, Inc.
SRPT
$17.56
+$0.03 (+0.17%)
1.8 B
Market Cap (Small Cap)
7%
IV Rank
65.0%
Implied Volatility
Aug 04
Next Earnings
Insider Trades
0 buys
2 sells
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| Jun 04, 2026 | Chambers Michael Andrew | Grant | 16,875 | $0 | |
| Jun 04, 2026 | Mayo Stephen | Grant | 16,875 | $0 | |
| Jun 04, 2026 | Boor Kathryn Jean | Grant | 16,875 | $0 | |
| Jun 04, 2026 | Nicaise Claude | Grant | 16,875 | $0 | |
| Jun 04, 2026 | Barry Richard | Grant | 16,875 | $0 | |
| Jun 04, 2026 | Wigzell Hans Lennart Rudolf | Grant | 16,875 | $0 | |
| Jun 04, 2026 | Connelly Deirdre P | Grant | 16,875 | $0 | |
| Jun 04, 2026 | BEHRENS M KATHLEEN | Grant | 16,875 | $0 | |
| Jun 04, 2026 | Chambers Michael Andrew | Other | 16,875 | $0 | |
| Jun 04, 2026 | Mayo Stephen | Other | 16,875 | $0 |
Politician Trades in SRPT
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| Apr 14, 2025 | Gil Cisneros | D | Sale | $1K-$15K |
| Jul 14, 2023 | Josh S. Gottheimer | D | Purchase | $1K-$15K |
| Jun 13, 2023 | Josh S. Gottheimer | D | Sale | $1K-$15K |
| Apr 10, 2023 | Daniel Goldman | D | Sale | $15K-$50K |
| Mar 06, 2023 | Josh S. Gottheimer | D | Purchase | $1K-$15K |
| Mar 06, 2023 | Daniel Goldman | D | Purchase | $15K-$50K |
| Jan 31, 2023 | Daniel Goldman | D | Sale | $1K-$15K |
Earnings History
| Date | Quarter | EPS Est. | EPS Actual | Surprise | Result |
|---|---|---|---|---|---|
| Mar 31, 2026 | Q1 2026 | $1.01 | $2.88 | +184.7% | Beat |
| Dec 31, 2025 | Q4 2025 | -$1.26 | -$3.93 | -213.0% | Miss |
| Sep 30, 2025 | Q3 2025 | -$0.83 | -$0.01 | +98.8% | Beat |
| Jun 30, 2025 | Q2 2025 | $0.77 | $1.89 | +146.8% | Beat |
| Mar 31, 2025 | Q1 2025 | -$0.97 | -$4.60 | -376.2% | Miss |
Track SRPT with ThetaPal
Get insider trade alerts, AI portfolio analysis, and options roll recommendations for SRPT and your entire portfolio.